August 23, 2023 – Page 13

Vistin Pharma ASA: Second quarter and first half 2023 financial results

Written by Customer Service on August 23, 2023. Posted in Earnings Releases And Operating Results.

Oslo, Norway, 23rd of August 2023 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the second quarter and first half of 2023. Revenue in the second quarter ended at MNOK 107 compared to MNOK 69 in Q2 2022. Increased volume from the new production line compared to the same quarter last year has resulted in more volumes available for sale. Revenue for first half of 2023 ended at MNOK 208 compared to MNOK 102 YTD last year, a 103% increase. Second quarter EBITDA ended at MNOK 19.6 (MNOK 4.7). EBITDA positively affected by increased sales volume, competitive electricity prices and a stronger EUR vs NOK, partly offset by a stronger USD vs NOK. In addition, economies of scale are materializing as the MEP volume ramps up. EBITDA for first half of 2023 ended at MNOK 33.7 compared to negative MNOK 13.5 YTD...

Gate terminal starts construction of 4th LNG tank at the port of Rotterdam

Written by Customer Service on August 23, 2023. Posted in Public Companies.

Gate terminal starts construction of 4th LNG tank at the port of Rotterdam Rotterdam, the Netherlands, 23 August 2023 07:00 CEST Gate terminal and its shareholders Gasunie and Vopak, are pleased to announce that the final investment decision has been taken to expand Gate terminal’s storage and regasification capacity. The expansion consists of a new LNG storage tank of 180,000 cubic meters and additional regasification capacity of 4 BCM per year. The new capacity is already rented out under long term commercial agreements and is expected to be ready for operation by the second half of 2026. Vopak and Gasunie are the founders and owners of Gate terminal in Rotterdam which has been operational since 2011. The terminal plays a crucial role in the supply and availability of gas in the Netherlands and its neighboring countries. Once all...

Biotalys Reports Half-Year 2023 Financial Results and Business Highlights

Written by Customer Service on August 23, 2023. Posted in Earnings Releases And Operating Results.

Ghent , Aug. 23, 2023 (GLOBE NEWSWIRE) — Press release – regulated information Strategic partnership with Syngenta to collaborate on the research and development and commercialisation of a new bio-insecticide Field trials with Evoca™* continue to demonstrate competitive performance in fruits and vegetables; trials now ongoing for additional crops such as blueberries and hemp Update on regulatory approval process for Evoca Successful CFO succession with Douglas Minder in function since July 1st Private placement of new shares for €7 million at market value Cash and cash equivalents amounted to €32 million end of June 2023 Management to host a conference call and live webcast today at 15:00 CEST / 14:00 BST / 09:00 EDT, details below Biotalys (Euronext – BTLS), an Agricultural Technology (AgTech) company developing...

Vow ASA: H1 2023 – Building for growth from a strong base

Written by Customer Service on August 23, 2023. Posted in Earnings Releases And Operating Results.

Vow ASA (OSE: VOW) reported continued high revenues of NOK 449 million in the first six months of 2023, representing a growth of 12 per cent year-over-year. EBITDA before non-recurring items came in at NOK 29.6 million for the period and corresponding to a margin of 6.6 per cent. EBITDA reflects good performance in cruise and heat treatment, and the costs of building pipeline in Industrial Solutions. “We are consistently delivering good results in our well-established business. We are strategically building capacity and intensifying our bidding for projects in new industry verticals. The demand for our offerings is evident, and we possess the relevance and capability to meet these needs. As a result, we remain steadfast in our commitment to seize these opportunities, even if it temporarily impacts our EBITDA,” said Henrik Badin, CEO of...

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on Phase III Skyscraper-01 study in PD-L1-high metastatic non-small cell lung cancer

Written by Customer Service on August 23, 2023. Posted in Public Companies.

Basel, 23 August 2023 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has been made aware of an inadvertent disclosure of the second interim analysis of the Phase III SKYSCRAPER-01 study, evaluating the investigational anti-TIGIT immunotherapy tiragolumab plus Tecentriq® (atezolizumab) versus Tecentriq alone as an initial (first-line) treatment for people with PD-L1-high locally advanced or metastatic non-small cell lung cancer (NSCLC). SKYSCRAPER-01 is ongoing and the study remains blinded to patients and investigators. We are continuing the study until the final analysis for overall survival. All other studies in the tiragolumab programme will continue as planned. The interim results for the primary endpoint of overall survival were not mature at the time of the second interim analysis, with median overall survival...

Lerøy Seafood Group ASA: Q2 2023 Results

Written by Customer Service on August 23, 2023. Posted in Earnings Releases And Operating Results.

HIGH REVENUE AND EARNINGS IMPROVEMENT Lerøy posted a 17% year-on-year increase in revenue for Q2 2023. Operating EBIT was NOK 950 million, up slightly from NOK 927 million in Q2 2022. Operating EBIT/kg through the value chain was NOK 28.7, against NOK 25.2 in the same period of last year. The second quarter has been impacted by price inflation on seafood products and a challenging situation in the Farming segment in the second half of 2022, which has resulted in low harvest weights and a low harvest volume in the first half of this year. The Group’s downstream activities showed a significant improvement from the same period of 2022 and, despite lower quotas this year, Wild Catch posted satisfactory results for Q2. Henning Beltestad explains that the long production time for salmon means it takes time for improved performance to be reflected...

Another record-breaking quarter for Mowi

Written by Customer Service on August 23, 2023. Posted in Earnings Releases And Operating Results.

(Bergen, 23 August 2023) Mowi recorded all-time high revenue of 1 365 million euros in the second quarter of 2023, compared with 1 232 million euros in the corresponding quarter of 2022. Operational profit was also strong at 300 million euros in the quarter. Mowi delivered yet another record-breaking set of results in the second quarter, driven by strong operational performance in all business areas in addition to good prices. “Strong volumes, good salmon prices and, most importantly, excellent operational performance by my 11 500 colleagues across the world, resulted in a new record-breaking quarter for Mowi. I am very pleased to see continuous improvement over time throughout the value chain,” Mowi CEO Ivan Vindheim said. Mowi harvested 107 500 tonnes of salmon in the quarter, above guidance of 104 500 tonnes. Full-year harvest guidance...

Nykode Therapeutics – Quarterly report Q2 2023

Written by Customer Service on August 23, 2023. Posted in Earnings Releases And Operating Results.

OSLO, Norway, Aug. 23, 2023 (GLOBE NEWSWIRE) — Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced its unaudited financial results for the second quarter and first half of 2023. The financial report can be accessed in the Investors section of the Company’s website: https://nykode.com/investors/financial-reports-and-presentations. The Company will host a webcast presentation at 3 p.m. CET / 9 a.m. ET. A live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website and on the following link: https://event.webcasts.com/starthere.jsp?ei=1630447&tp_key=80c6064a80. About Nykode TherapeuticsNykode Therapeutics is a clinical-stage biopharmaceutical company dedicated to the...

Rigid Packaging Market to Surpass 492.3 Billion by 2030 Drives Due to the Strong Emphasis on Food Packaging

Written by Customer Service on August 23, 2023. Posted in Mergers And Acquisitions.

SkyQuest projects that the rigid packaging market will attain a value of USD 492.3 billion by 2030, with a CAGR of 3.6% over the forecast period (2023-2030). The rigid packaging market has experienced substantial growth due to the increasing demand for rigid plastic packaging from the healthcare industry. This demand stems from the crucial need to protect medicines and medical products from contamination. The healthcare sector requires packaging solutions that comply with rigorous international regulatory standards to ensure the safety and integrity of the contents. Westford, USA, Aug. 22, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the Flexible Packaging Association has highlighted that flexible packaging is predominant in the food sector, representing over 60% of the overall rigid packaging market. This strong emphasis on...

Mill Liner Market Set to Soar Past USD 176.33 Billion by 2030

Written by Customer Service on August 23, 2023. Posted in Mergers And Acquisitions.

The global Mill Liner market size is expected to reach USD 176.33 billion by 2030 and exhibit a CAGR of 7.3% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing demand for minerals and metals, growing emphasis on operational efficiency and productivity, the introduction of innovative mill liner materials and designs, and stringent regulations and safety standards in the mining industry are fueling the market’s growth. Westford, USA, Aug. 22, 2023 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Mill Liner market, increasing adoption of advanced composite materials, growing demand for longer-lasting and more durable mill liners, shift towards customized mill liner solutions, rising focus on optimizing mill performance and reducing downtime,...

Day: August 23, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice